The Kable

The Kable

Share this post

The Kable
The Kable
💉CRISPR on the move, FDA on the move too, Novavax moves but doesn’t supply, drug companies are competing to scratch an itch
Copy link
Facebook
Email
Notes
More
Friday Kable

💉CRISPR on the move, FDA on the move too, Novavax moves but doesn’t supply, drug companies are competing to scratch an itch

Combating opioid addictions; A Beta vaccine dies; Treat peanut allergy sufferers with compassion

Vinod's avatar
Vinod
Feb 11, 2022
∙ Paid
1

Share this post

The Kable
The Kable
💉CRISPR on the move, FDA on the move too, Novavax moves but doesn’t supply, drug companies are competing to scratch an itch
Copy link
Facebook
Email
Notes
More
Share

Spotlight

Over at Stat News, they’ve overhauled their CRISPR tracker to help you make sense of the spate of advancements in CRISPR tech. Check it out! Stat News also writes about how more and more drugs using CRISPR 2.0 are reaching trials faster than ever before.

Keep reading with a 7-day free trial

Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 The Kable
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More